Literature DB >> 29058872

Bile Acid Recognition by Mouse Ileal Bile Acid Binding Protein.

Mohsen Badiee1, Gregory P Tochtrop1.   

Abstract

Ileal bile acid binding protein (I-BABP, gene name FABP6) is a component of the bile acid recycling system, expressed in the ileal enterocyte. The physiological role of I-BABP has been hypothesized to be either an intracellular buffering agent to protect against excess intracellular bile acids or separately as a modulator of bile acid controlled transcription. We investigated mouse I-BABP (mI-BABP) to understand the function of this protein family. Here, we studied energetics and site selectivity of binding with physiological bile acids using a combination of isothermal calorimetric analysis and NMR spectroscopy. We found that the most abundant bile acid in the mouse (β-muricholic acid) binds with weak affinity individually and in combination with other bile acids. Further analysis showed that mI-BABP like human I-BABP (hI-BABP) specifically recognizes the conjugated form of cholic acid:chenodeoxycholic acid (CA:CDCA) in a site-selective manner, displaying the highest affinity of any bile acid combination tested. These results indicate that I-BABP specifically recognizes the ligand combination of CDCA and CA, even in a species such as the mouse where CDCA only represents a trace component of the physiological pool. Specific and conserved recognition of the CDCA and CA ligand combination suggests that I-BABP may play a critical role in the regulation of bile acid signaling in addition to its proposed role as a buffering agent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29058872     DOI: 10.1021/acschembio.7b00865

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  5 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies.

Authors:  Alyssa Kriegermeier; Richard Green
Journal:  Front Med (Lausanne)       Date:  2020-05-05

3.  L-Arabinose improves hypercholesterolemia via regulating bile acid metabolism in high-fat-high-sucrose diet-fed mice.

Authors:  Yu Wang; Jiajia Zhao; Qiang Li; Jinxin Liu; Yujie Sun; Kuiliang Zhang; Mingcong Fan; Haifeng Qian; Yan Li; Li Wang
Journal:  Nutr Metab (Lond)       Date:  2022-04-15       Impact factor: 4.654

4.  Medium-chain fatty acids decrease serum cholesterol via reduction of intestinal bile acid reabsorption in C57BL/6J mice.

Authors:  Huizi Li; Yinghua Liu; Xinsheng Zhang; Qing Xu; Yong Zhang; Changyong Xue; Changjiang Guo
Journal:  Nutr Metab (Lond)       Date:  2018-06-05       Impact factor: 4.169

5.  Transcriptome analysis reveals mechanism underlying the differential intestinal functionality of laying hens in the late phase and peak phase of production.

Authors:  Wei-Wei Wang; Jing Wang; Hai-Jun Zhang; Shu-Geng Wu; Guang-Hai Qi
Journal:  BMC Genomics       Date:  2019-12-12       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.